A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2‐negative metastatic breast cancer

A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2‐negative metastatic breast cancer

Abstract Background This single‐arm prospective phase II trial was performed to assess the efficacy and safety of the dual oral metronomic vinorelbine and capecitabine (mNC) regimen in women with HER2‐negative metastatic breast cancer (MBC) in China. Methods The mNC regimen was administered to the e...

Full description

Bibliographic Details
Main Authors: Yue Chai, Jiaxuan Liu, Mingxia Jiang, Maiyue He, Zijing Wang, Fei Ma, Jiayu Wang, Peng Yuan, Yang Luo, Binghe Xu, Qiao Li
Format: Article
Language:English
Published: Wiley 2023-08-01
Series:Thoracic Cancer
Subjects:
breast cancer
capecitabine
metastasis
metronomic chemotherapy
vinorelbine
Online Access:https://doi.org/10.1111/1759-7714.15011

Similar Items

Similar Items